September 10, 2025Diseases of the Esophagus

Treatment Experience of Esophageal Fistula Induced by Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma: A Single-Center Experience

View Full Paper

Ask AI

Bookmark

Authors

GZGuoqing ZhangChinese Academy of Sciences TMTeng MuInner Mongolia Electric Power (China)JWJunya WangMinistry of Science

Discussion

Member takes

Implication

Retrospective analysis reveals treatment outcomes for esophageal fistula in patients receiving neoadjuvant therapy for esophageal squamous cell carcinoma, highlighting surgical intervention importance.

Key Points

Active surgical intervention improves outcomes for patients with esophageal fistulas after treatment.
Patients who underwent surgery showed a median survival of 12.2 months, contrasting with 6.7 months for those not receiving surgery.
A total of 12 patients developed esophageal fistulas during treatment, with various types identified and analyzed for outcomes.
Infection risks, such as pyothorax, were noted in patients undergoing surgical procedures, necessitating close monitoring.

Cite This Study

Zhang et al. (2025) studied this question.

synapsesocial.com/papers/68c23cf6b210217d6478b897 https://doi.org/10.1093/dote/doaf061.076

View Full Paper

Ask AI

Bookmark